Far from being historically considered a primary healthcare problem, tricuspid regurgitation
(TR) has recently gained much attention from the scientific community. In fact, in the last …

Tricuspid regurgitation (TR) aetiologies are currently divided into primary and secondary TR.
Intrinsic abnormalities of the tricuspid valve leading to significant TR (primary) are rare and …

Tricuspid regurgitation (TR) has long been a forgotten valve disease of benign reputation.
However, TR deserves higher attention and represents a growing public health crisis …

Significant tricuspid regurgitation (TR) is a common finding, affecting about one in twenty-
five subjects among the elderly and presenting more frequently in women than in men. This …

Compared with the vast literature concerning the prevalence, pathophysiology, and outcome
of left valvular disease, the data concerning tricuspid regurgitation (TR) is very limited. In this …

Aims The impact of tricuspid regurgitation (TR) in patients with left ventricular systolic
dysfunction on presentation and clinical outcome is uncertain due to confounding …

Severe tricuspid valve regurgitation has been for a long time a neglected valve disease,
which has only recently attracted increasing interest due to the notable negative impact on …

Within a decade, valvular heart disease graduated to centre stage with the introduction of
catheter-based interventions such as transarterial valve implantation or TAVI 1–3 and …

Aims Tricuspid regurgitation (TR) is a frequent echocardiographic finding; however, its effect
on outcome is unclear. The objectives of current study were to evaluate the impact of TR …

The early publication of Braunwald et al. 1 advocated for conservative management of
tricuspid regurgitation (TR) in patients undergoing mitral valve surgery, resulting in a general …